800 - 460 - 5832
x

Webinars and Video Resources

Webinars

The Save Your Skin Foundation webinars are a great way to stay updated by listening to patients, survivors, doctors, and pharmaceutical company executives discuss the melanoma landscape. Each webinar features a variety of experts and discusses a different topic. Below is information on upcoming webinars, and links to audio recordings of past webinars.

Upcoming Webinars:

Stay tuned for information about our upcoming webinars here!

 

Past webinars (some with audio recording):

 

Current Melanoma Treatments in Canada: What Patients Need to Know

Thursday, March 9, 2017 at 2pm EST, 12pm MDT, 11am PST

With Dr. Wilson Miller, Professor in the Departments of Oncology and Medicine, McGill University and Director of the Clinical Research Unit at the Jewish General Hospital

The learning objectives of this webinar are to educate patients on the current landscape of melanoma treatments in Canada, which treatment options are on the horizon, and the clinical trials for melanoma currently underway in Quebec.

Missed the webinar? Listen to a recording of the presentation here!

 

Clinical Trials: What Patients Need to Know

Thursday, February 9, 2017, 2pm EST, 12pm MDT, 11am PST

With Dr. Natasha Kekre, Associate Scientist, Clinical Epidemiology Program, Ottawa Hospital Research Institute

The learning objectives of this webinar are to educate patients about clinical trials: where to find information about them, what their purpose is, how they work, who is eligible, and why you should participate. Clinical trials may consist of a variety of new or previously existing treatment methods, and their ultimate goal is to establish whether a new test or treatment safely works for patients. This webinar will discuss the important position clinical trials hold in the treatment of cancers and other illnesses and provide the patient with information regarding the process of finding and participating in clinical trials, their eligibility for clinical trials, and any other questions they might have.

Missed the webinar? Listen to a recording of the presentation here.

 

Understanding your Pathology Report
With Dr. Alan Spatz, MD
Director, Pathology Department, Jewish General Hospital &
Professor, Pathology and Oncology, McGill University

Thursday, October 13, 2016 at 12pm EDT, 10am MDT, 9am PDT
To diagnose diseases such as cancer, a sample of tissue called a biopsy is taken from a patient and examined by a pathologist to determine if cancer is present. A pathologist will then examine specimens removed during surgery (resections) for conditions such as cancer, to determine whether the tumour is benign or cancerous, and if cancerous, the exact cell type, grade and stage of the tumour. The pathologist, who is a member of your medical team, writes the pathology report that your treating doctor uses to provide the best care for you as a patient. In this webinar, Dr. Alan Spatz, Director of the Pathology Department at the Jewish general Hospital in Montreal, will provide insight on understanding your pathology report so that you can play an active role in your treatment.

Dr. Alan Spatz, MD
Dr. Alan Spatz is Director of the Pathology Department at the Jewish General Hospital, and Professor of Pathology and Oncology at McGill University and holds a Canada Research Chair in Molecular Pathology. Dr. Spatz presently directs the X chromosome and Cancer research lab at the Lady Davis Institute and leads an international research group on cutaneous melanoma. He has authored more than 180 original scientific papers, reports, review articles, and books.
Dr. Spatz is also the Director of the McGill-JGH Dubrovsky Molecular Pathology Centre located at the Jewish General Hospital, which opened at the end of 2013. This new cutting- edge facility is leading the way to personalized medicine by using molecular analysis to identify tumour biomarkers to advance the diagnosis and treatment of cancer.

Missed the webinar? Listen to a recording of the presentation here.

 

Choosing the Right Sunscreen
With Renée-Claude Lachapelle, Medical Development Specialist, L’Oréal Canada
Thursday, September 1, 2016 at 12pm EST, 10am MST, 9am PST

Choosing the right sunscreen can be difficult. When picking the right product, you may be asking yourself questions such as, what does sun protection factor (SPF) mean? Or, what’s the difference between an expensive sunscreen and one purchased at your corner store, how much do I need and is there a difference between SPF 30 and 60?  Sunscreen is an important part of skin cancer prevention, but also in reducing damage to the skin from sun exposure. In this Webinar, we will discuss what to consider when buying sunscreen, proper application for prevention of sun burns, what the ingredients means and other factors for consideration. This webinar aims to identify key questions of sunscreen protection in order to help you to prevent skin cancer and to reduce damage to the skin caused by sun.

Join us as Renée-Claude Lachapelle, Medical Development Specialist at L’Oréal Canada will provide us with an overview on everything sunscreen related to help guide consumers to the right sunscreen for you.

Post-ASCO Webinar with Dr. Omid Hamid

With Dr. Omid Hamid, Director of the Melanoma Center at The Angeles Clinic and Research Institute
Friday, August 26, 2016 at 4pm PDT/ 5pm MDT / 7pm EDT

This webinar will review late breaking news, key takeaways, clinical data and other updates presented at the 2016 American Society of Clinical Oncology (ASCO) Annual Meeting that took place this past June in Chicago, Illinois. Dr. Omid Hamid will share his key insights into what the landscape of melanoma treatment looks like for the near future.

As the  Director of the Melanoma Center at The Angeles Clinic and Research Institute, Dr. Omid Hamid works to ensure that patients receive access to the most up-to-date therapeutics, based on molecular pathways of melanoma progression.  Most recently, in his role with the Phase 1 Developmental Therapeutics Program, Dr. Hamid has been instrumental in bringing new therapies from the investigational lab to the clinic for patient benefit.  These therapies involve immunological therapies such as PD-1 inhibitors, therapies against tumor angiogenesis, and targeted agents that block internal processes in tumor cell’s function.

Missed the webinar? Listen to a recording of the presentation here.

The Pharmacoeconomics of Cancer Drugs
February 26, 2016 12pm EST | 10am MST | 9am PST

With new breakthroughs in cancer care and the subsequent rise in costs for these treatments, health economics is playing an increasingly important role in health care. What is pharmacoeconomics and what role does it play in the Canadian Health Care System and in the reimbursement decision-making process? Join us as Professor of Economics at Université de Montreal and Head, Oncology Policy and Reimbursement at Novartis Canada provides a greater understanding of what pharmacoeconomics is from a Canadian perspective and what this means for the cancer patient.

Frédéric Lavoie obtained his Master’s Degree in Economics in 1995 from Université du Québec à Montréal. Until 1998, he worked as a health economist at the Centre for the Analysis of Cost-Effective Care within the Division of Clinical Epidemiology, a research unit affiliated with McGill University. In this position, he worked on and authored different papers on economic evaluation of pharmaceuticals. In 1997, Frederic was part of a working group of researchers mandated by the Government of Quebec to evaluate the economic impact of the proposed tobacco legislation. Frederic began his career in the pharmaceutical industry when he joined Pfizer Canada in 1998 where he occupied various roles of increasing responsibilities. He joined Novartis Oncology in October 2014 as Head of Health Policy and Patient Access. He has also kept close links with the academic field as he has graduated in 2007 as a Ph.D. in Biomedical Sciences under the supervision of Dr. Jacques LeLorier at Universite de Montreal. Frederic also serves on the editorial board of the International Journal of Technology Assessment in Health Care.

Missed the webinar? Listen to a recording of the presentation here.

 

Melanoma: A Year at a Glance
January 29, 2016
7am EST | 4am PST | 2pm Central European Time

The Save Your Skin Foundation presents a new series of medical webinars aimed at Canada’s health care professionals who are working in the area of skin cancer. This webinar facilitates an open discussion with oncologists on what was new in melanoma treatment options in 2015 and what we hope to see in 2016. The panel will bring together Dr. Omid Hamid, Director of the Melanoma Center at The Angeles Clinic and Research Institute; Dr. Reinhard Dummer, Vice-Chairman of the Department of Dermatology and Head of the Skin Cancer Unit at the University Hospital of Zürich; and Dr. Wilson Miller, Professor of Departments of Oncology and Medicine, McGill University and Director of the Clinical Research Unit at the Jewish General Hospital in Montreal, Quebec.

Missed the webinar? Listen to a recording of the presentation here.

 

Post-SMR Webinar
January 14, 2016
12pm EST | 10am MST | 9am PST

The first medical webinar in our new “Spotlight on Skin Cancer” series, will be a Post-Society for Melanoma Research Conference with Dr. Winson Y. Cheung, Medical Oncologist at the British Columbia Cancer Agency. Dr. Cheung will share updates and key findings presented at the 2015 Society for Melanoma Conference in San Francisco, California.
As well as the information provided, participants will have the opportunity to discuss key takeaways, late breaking news and clinical data with colleagues from across Canada.

Dr. Winson Y. Cheung is a medical oncologist at the British Columbia Cancer Agency – Vancouver Centre Clinic and specializes in the treatment of head & neck as well as gastrointestinal malignancies. He is the recipient of numerous accolades, including the National Cancer Institute of Canada Dorothy Lamont Award, the Novartis Oncology Canadian Investigator Award, the Multinational Association of Supportive Care in Cancer Investigator Award, and several American Society of Clinical Oncology Merit Awards. His primary research interest is health services and outcomes research with the aim to ensure appropriate access to cancer care and enhance delivery of cancer therapies to all patients.

Missed the webinar? Listen to a recording of the presentation here.

 

The Drug Evaluation Process: Patient Input Submissions and Responsible Advocacy for New Treatment

Date held: Thursday, December 17, 2015 – 2:00 AM EST \ 12:00 PM MST \ 11:00 AM PST
Speakers: Bill Dempster from 3Sixty Public Affairs
Topic:  This webinar will dive into the process used to evaluate drugs, concluding with recommendations about whether they should be covered by provincial formularies. In particular, this webinar will look at how patients can engage in the process. Following the presentation, there will be a live Q&A. The presentation will address the following topics:

When and how can patients engage with the drug evaluation process?
What are the best practices to promote the patient’s voice?
Looking ahead: how can we improve patients’ opportunities to engage?

The webinar will be hosted by Bill Dempster of 3Sixty Public Affairs. As CEO of 3Sixty Public Affairs, Bill Dempster helps health charities, businesses and associations understand health policy and effectively engage with governments. He applies business, health policy, legal and government experience to find mutually beneficial solutions to complex problems.

Missed the webinar? Listen to a recording of the presentation here.

 

Canadian Cancer Therapy Approval, Evaluation and Funding Process: What is the Role of the Patient?

Date held: Tuesday, December 8, 2015 – 2:00 AM EST \ 12:00 PM MST \ 11:00 AM PST
Speakers: Gerry Jeffcott and Bill Dempster from 3Sixty Public Affairs
Topic: This webinar will provide insight into how cancer drugs are reviewed by Health Canada, through the multi-step decision-making process that determines whether they are covered by public and private formularies. The presenters will host a live question and answer session following the presentation. The presentation will address the following topics:
What are the different steps to bring a new cancer drug to patients?
Where can patients make a difference?
How is the patient role changing?

Gerry Jeffcott is a senior associate at 3Sixty Public Affairs who has almost 25 years of health and pharmaceutical policy experience. He is a recognized expert in the Canadian reimbursement review and approval process for new medications and a sought after commentator on relevant policy questions.
As CEO of 3Sixty Public Affairs, Bill Dempster helps health charities, businesses and associations understand health policy and effectively engage with governments. He applies a deep business, health policy, legal and government experience to find mutually beneficial solutions to complex problems.

Missed the webinar? Listen to a recording of the presentation here.

 

Surviving Melanoma: A Discussion on Survivorship

Date held: Thursday, April 30th, 2015-9:45 AM PST

Speakers: Kathy Barnard, Nigel Deacon, Terry Jaillet, Natalie Richardson

Topic: Life after cancer can be anything but ordinary. Join Kathy Barnard, President and Founder of the Save Your Skin Foundation, along with a panel of survivors from across Canada as they discuss their personal stories, struggles, triumphs, what survivorship means and how they got there. Melanoma month kicks off with this webinar to inspired hope that surviving cancer is possible, whether you have melanoma or another form of cancer.

Missed the webinar? Listen to a recording of the presentation here.

 

Are you Ready for your Meeting with your Oncologist?

Date held: Wednesday, March 18th, 2015- 10 AM PST

Speakers: Laura Wilson, Symptoms Management and Drug Access Nurse- Lions Gate Hospital, North Vancouver

Topic: In this webinar, Laura Wilson discusses the important factors to consider before meeting your Oncologist so that you can ask the right questions to make informed decisions and be an active participant in your cancer care.

Questions asked after the webinar include: At which point should an Oncologist be part of my team if I am diagnosed with stage 1 or 2 (or maybe 3) melanoma? Should I be seeing an Oncologist even if I had my melanoma surgically removed by my Dermatologist?

Laura Wilson’s answer: It never hurts to be referred, it is probably less important for a stage 1 but is definitely important for a stage 2 or 3.

Missed the webinar? Listen to a recording of the presentation here.

View the slides from this presentation on slideshare here.

 

Le Cancer de la Peau au Quebec (French)

Date held: Friday, Februrary 27, 2015- 10 AM PST

Speaker: Dr. Claveau, Dermato-Oncologist- Hopital Dieu de Quebéc, Quebéc

Topic: In this webinar, Dr. Claveau prevents an overview of skin cancer in Quebéc and treatment options, with a focus on melanoma.

 

The Melanoma Landscape in Canada Today

Date held: Friday, February 13, 2015- 10 AM PST

Speaker: Dr. Michael Smylie, Medical Oncologist- Cross Cancer Institute, Edmonton, Alberta

Topic: Over the past few years, the landscape of melanoma has changed dramatically with the arrival of new therapies. In this webinar, Dr. Smylie walks us through those changes and helps us to understand what treatment options are available today.